E-LIB Suche - Ergebnisse für: Kiyosue, Arihiro

1

WCN24-1980 Efficacy and safety of zibotentan in combination..:

Heerspink, Hiddo Lambers ; Kiyosue, Arihiro ; Wheeler, David...
Kidney International Reports. 9 (2024) 4 - p. S96 , 2024

Link: https://doi.org/10.1016/..

2

Change in pulse pressure and cardiovascular outcomes after ..:

Nochioka, Kotaro ; Nakayama, Masaharu ; Akashi, Naoyuki...
IJC Heart & Vasculature. , 2024

Link: https://doi.org/10.1016/..

3

Efficacy, Safety, and Pharmacokinetics of Inclisiran in Jap..:

Yamashita, Shizuya ; Kiyosue, Arihiro ; Maheux, Pierre...
Journal of Atherosclerosis and Thrombosis. , 2024

Link: https://doi.org/10.5551/..

4

Potential value of saline-induced Pd/Pa ratio in patients w..:

Kiriyama, Hiroyuki ; Kiyosue, Arihiro ; Minatsuki, Shun...
Frontiers in Cardiovascular Medicine. 9 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

5

Zibotentan in combination with dapagliflozin compared with ..:

Heerspink, Hiddo J L ; Kiyosue, Arihiro ; Wheeler, David C...
The Lancet. 402 (2023) 10416 - p. 2004-2017 , 2023

Link: https://doi.org/10.1016/..

6

Hyperuricemia predicts increased cardiovascular events in p..:

Akashi, Naoyuki ; Kuwabara, Masanari ; Matoba, Tetsuya...
Frontiers in Cardiovascular Medicine. 9 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Impact of heart failure severity and major bleeding events ..:

Ikebe, So ; Ishii, Masanobu ; Otsuka, Yasuhiro...
International Journal of Cardiology Cardiovascular Risk and Prevention. 18 (2023) - p. 200193 , 2023

Link: https://doi.org/10.1016/..

8

Safety and efficacy analyses across age and body mass index..:

Kiyosue, Arihiro ; Dunn, Julia P. ; Cui, Xuewei...
Diabetes, Obesity and Metabolism. 25 (2023) 4 - p. 1056-1067 , 2023

Link: https://doi.org/10.1111/..

9

Relationships Among Heart Rate, β-Blocker Dosage, and Progn..:

Oba, Yusuke ; Kabutoya, Tomoyuki ; Kohro, Takahide...
Circulation Journal. 87 (2023) 2 - p. 336-344 , 2023

Link: https://doi.org/10.1253/..

10

BNP level predicts bleeding event in patients with heart fa..:

Otsuka, Yasuhiro ; Ishii, Masanobu ; Ikebe, So...
Open Heart. 10 (2023) 2 - p. e002489 , 2023

Link: https://doi.org/10.1136/..

11

Safety and Effectiveness of Alirocumab, a Proprotein Conver..:

Kiyosue, Arihiro ; Yasuda, Satoshi ; Tomura, Akiyoshi..
Circulation Journal. 87 (2023) 6 - p. 834-846 , 2023

Link: https://doi.org/10.1253/..

12

Sex Differences in Long-Term Outcomes in Patients With Chro..:

Akashi, Naoyuki ; Matoba, Tetsuya ; Kohro, Takahide...
Circulation Journal. 87 (2023) 6 - p. 775-782 , 2023

Link: https://doi.org/10.1253/..

13

Asymptomatic myocardial infarction in a patient with myoton..:

Seki, Yuka ; Yamada, Takanobu ; Kiyosue, Arihiro...
Journal of Cardiology Cases. 26 (2022) 4 - p. 248-251 , 2022

Link: https://doi.org/10.1016/..

14

Mediators of the effects of canagliflozin on N‐terminal pro..:

Tanaka, Atsushi ; Imai, Takumi ; Suzuki, Makoto...
Diabetes, Obesity and Metabolism. 24 (2022) 5 - p. 962-965 , 2022

Link: https://doi.org/10.1111/..

15

Characteristics and in-hospital outcomes of patients underg..:

Minatsuki, Shun ; Takahara, Mitsuyoshi ; Kiyosue, Arihiro...
Open Heart. 8 (2021) 2 - p. e001721 , 2021

Link: https://doi.org/10.1136/..